纤维肌痛管理的神经营养方法:叙述性审查
Anastasiia Badaeva1, Alexey Danilov2, Anastasiia Kosareva2
1Department for Pathological Physiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991, Moscow, Russia. badaeva_a_v@staff.sechenov.ru.
Pain and therapy
|July 23, 2024
概括
纤维肌痛 (FM) 管理可能受益于神经营养. 饮食干预和补充剂在减少慢性疼痛,疲劳和其他FM症状方面表现有前途,提供了整体的方法.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
- 类风湿病学 类风湿病学
背景情况:
- 纤维肌痛 (FM) 是一种普遍的慢性疾病,影响全球数百万人,其特点是普遍的疼痛和疲劳.
- FM的确切原因尚不清楚,但遗传学,环境和包括营养在内的心理因素都与此有关.
- 目前的FM管理往往是症状性的,缺乏普遍接受的指导方针和有效的治疗方法.
研究的目的:
- 探索神经营养作为纤维肌痛补充治疗的潜力.
- 综合现有关于营养与 FM 症状管理之间的联系的研究.
- 突出特定的饮食干预措施和补充剂,可以缓解FM症状.
主要方法:
- 这项研究是对现有科学文献的叙事性审查.
- 它综合了有关营养因素及其对 FM 症状的影响的研究.
- 该审查审查了各种补充剂和饮食模式的证据.
主要成果:
- 营养干预措施,包括维生素D,和益生菌,显示出减少FM症状的潜力,如疼痛,疲劳和睡眠障碍.
- 减肥,植物性饮食和低FODMAPs饮食可以改善 FM 患者的生活质量和管理胃肠道问题.
- 补充剂如CoQ10,omega-3脂肪酸和B12可能通过抗炎和神经递质调节机制提供好处.
结论:
- 神经营养提供了一个有希望的整体方法来管理纤维肌痛症状.
- 饮食干预和特定的补充剂可以成为对FM有价值的补充策略.
- 需要进一步的研究和临床试验,以建立FM管理的最终饮食指南.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome III: Medical and Nursing Management
189
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
189
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
478
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
478


